Goniotriol is primarily studied for its biological activity, particularly in ophthalmology. It has shown potential in regulating intraocular pressure, making it a subject of interest for research into glaucoma treatment. The compound may influence aqueous humor dynamics in the eye, possibly through trabecular meshwork pathways. Additionally, goniotriol exhibits anti-inflammatory properties, which could contribute to protecting retinal cells and supporting overall eye health. Due to its natural origin and structural characteristics, it serves as a lead compound in developing new ocular therapeutics. Research remains mostly in preclinical stages, focusing on its mechanism and efficacy in models of eye disease.